MENU

NBIX Neurocrine Biosciences Forecast, Technical & Fundamental Analysis

a product based biopharmaceutical company

NBIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
NBIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NBIX is expected to report earnings to fall 6.13% to $1.53 per share on October 29

Neurocrine Biosciences NBIX Stock Earnings Reports
Q3'24
Est.
$1.53
Q2'24
Beat
by $0.50
Q1'24
Beat
by $0.13
Q4'23
Beat
by $0.33
Q3'23
Beat
by $0.49
The last earnings report on August 01 showed earnings per share of $1.63, beating the estimate of $1.13. With 528.79K shares outstanding, the current market capitalization sits at 13.72B.
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDTX11.950.25
+2.14%
Cidara Therapeutics
ALPACA.X0.178406-0.000621
-0.35%
Alpaca Finance cryptocurrency
SITE133.09-1.21
-0.90%
SiteOne Landscape Supply
EPC36.07-0.64
-1.74%
Edgewell Personal Care Company
VHI27.90-0.86
-2.99%
Valhi

NBIX and Stocks

Correlation & Price change

A.I.dvisor tells us that NBIX and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
-1.28%
ACET - NBIX
25%
Poorly correlated
-3.38%
SNDL - NBIX
23%
Poorly correlated
-0.47%
AVDL - NBIX
23%
Poorly correlated
+1.05%
IMCC - NBIX
23%
Poorly correlated
-5.56%
ZOM - NBIX
23%
Poorly correlated
-0.86%
More